Distinct T FH subsets that influence specific class-switching events are assumed to exist, but the accumulation of isotype-specific T FH subsets in secondary and tertiary lymphoid organs has not been hitherto demonstrated. IL-4 expressing T FH cells are surprisingly sparse in human secondary lymphoid organs. In sharp contrast, in IgG4-related disease (IgG4-RD), a disorder characterized by polarized Ig class switching, most T FH cells in tertiary and secondary lymphoid organs make IL-4. Human IL-4 + T FH cells do not express GATA-3 but express nuclear BATF, and the transcriptomes of IL-4 secreting T FH cells differ both from PD1 hi T FH cells that do not secrete IL-4 and IL4-secreting non-T FH cells. Unlike IgG4-RD, IL-4 + T FH cells are rarely found in tertiary lymphoid organs in Sjögren's syndrome, a disorder in which IgG4 is not elevated. The proportion of CD4 + IL-4 + BATF + T cells as well as of CD4 + IL-4 + CXCR5 + T cells in IgG4-RD tissues correlates tightly with tissue IgG4 plasma cell numbers and plasma IgG4 levels in patients but not with the total plasma levels of other isotypes. These data describe a disease-related T FH sub-population in human tertiary and secondary lymphoid organs that is linked to IgG4 class switching.
INTRODUCTION
T follicular helper (T FH ) cells provide help to B cells during T-dependent immune responses and they contribute to isotype switching, somatic hypermutation, germinal center formation and the selection of high affinity B cells in the germinal center (Crotty, 2011; King et al., 2008; Vinuesa et al., 2005) .
Exactly how T FH cells provide specificity to class switching events is unclear. The idea that unique T FH subsets separately and specifically drive class switching to different Ig isotypes is attractive, but no in vitro or in vivo data exist to firmly establish this notion. Indeed, there have been no studies using multicolor staining approaches to examine human T follicular helper cells in situ in secondary or tertiary lymphoid organs. The possibility that chronic disease states exhibiting polarized isotype switching could provide novel insights about specialized T FH cells served as the rationale for undertaking this study. Some evidence for specialized T FH subsets, albeit indirect, comes from studies of circulating human T FH cells that have described three T FH subsets defined on the basis of chemokine receptor expression patterns. The relationship between blood T FH cell subsets and T FH cells in secondary or tertiary lymphoid organs remains unclear. In the studies of Ueno et al. (Morita et al., 2011; Ueno et al., 2015) on blood T FH subsets, T FH1 cells secrete IFN-upon activation and have limited isotype-switching activity when examined in in vitro co-culture experiments. T FH2 cells secrete IL-4 after many days of in vitro stimulation and can mediate class switching to IgA, IgE and essentially all IgG isotypes, including IgG4. T FH17 cells secrete IL-17 following activation and are equally promiscuous.
Although all T FH cells may have the potential to secrete IL-4, one report has described polarized IL-4 secreting T FH cells in mice in the context of an allergic disease model, and it was suggested that these cells could subsequently differentiate into T H2 cells (Ballesteros-Tato et al., 2016) . An illuminating study using reporter mice has led to the view that T FH cells initially make IL-21, mature into cells that make IL-21 and IL-4, and eventually make IL-4 alone (Weinstein et al., 2016) . These studies also demonstrated that the use of a Type 2 responselinked murine pathogen facilitated the induction of IL-4 secreting "T FH4 " cells.
There have been no other reports establishing the existence of functionally distinct T FH subsets in human or murine secondary or tertiary lymphoid organs.
Moreover, no cytokine-expressing subset of these cells in tissue sites has been linked so far to any specific disease, nor have T FH subsets been defined that determine specific polarized class-switching events. How the overall transcriptome of an IL-4 secreting T FH cell population may differ from other T FH cell types has also never been determined, since such cells have not previously been purified from secondary or tertiary lymphoid organs.
IgG4-related disease is a chronic inflammatory disease characterized by tumescent lesions with characteristic storiform fibrosis, obliterative phlebitis and a marked lymphoplasmacytic infiltrate that includes a large proportion of IgG4positive plasma cells (Kamisawa et al., 2015; Mahajan et al., 2014) . Circulating expansions of plasmablasts, most of which express IgG4, are a hallmark of active disease . We have shown that circulating plasmablasts are heavily somatically hypermutated, implying that these B lineage cells are derived from germinal centers. We have also shown that subjects with IgG4-RD exhibit large clonal expansions of CD4 + CTLs, the dominant T cells in disease tissues, and that these cells are activated at lesional sites, where they secrete IL-1, TGF-and IFN- (Mattoo et al., 2016; Maehara et al., 2017) . Although an increase in blood T FH2 cells has been noted in IgG4-RD (Akiyama et al., 2015; Akiyama et al., 2016) , these cells function promiscuously in vitro, as they can facilitate class switching to multiple isotypes in co-culture experiments. There is no evidence so far connecting blood T FH cell subsets to any functional counterparts in secondary or tertiary lymphoid organs.
Multi-color staining approaches have hitherto not been used to examine lymphoid organ T FH cells in situ. We show here, using such an approach, that T FH cells making IL-4 are surprisingly sparse in normal human tonsils and mesenteric lymph nodes. However, IL-4 and BATF expressing T FH cells are dramatically expanded in IgG4-RD tertiary lymphoid organs and lymph nodes, frequently making up more than half of all T FH cells. This subset of human T FH cells can be found in association with AID expressing B cells, is more frequent in extra-follicular sites than in the light zone, and is linked to specific class switching to IgG4.
Isolating T cell subsets based on their function, such as secretion of their cardinal cytokine, and characterizing their gene expression profiles can help us gain better insights into the biology of specific T FH subsets, as well as define better surface markers for their flow cytometric identification. We therefore used an IL4-capture assay followed by FACS sorting, to isolate IL4-secreting T FH cells from a human tonsil and compared their transcriptomic profiles with CXCR5 hi PD1 hi IL4tonsillar T FH cells and IL4-producing CXCR5non-T FH cells (T H2 cells). Our studies validate the notion of functionally distinct T FH subsets, establish a link between tissue and lymphoid organ human IL-4 secreting T FH cells and IgG4-related disease, and identify genes that are specifically expressed in and define the human IL-4 secreting T FH cell subset.
RESULTS

CD4 + ICOS + IL-4 + T cells are sparse in normal tonsils and lymph nodes
We initially examined normal tonsils to quantitate CD4 + ICOS + T cells that express IL-4 in situ. Almost all the IL-4 expressing cells seen in tonsils were CD4 + , but did not express ICOS (Fig. 1, A and B) . These CD4 + IL-4 + ICOS -T cells are presumably T H2 cells that reside in T cell zones in tonsils. Quantitation revealed that CD4 + ICOS + IL-4 + T FH cells represent less than 0.5% of all CD4 + ICOS + T FH cells in normal tonsils and lymph nodes (Fig. 1C ). On the other hand, quantitative analyses revealed that about 40% of CD4 + ICOS + T FH cells in an IgG4-RD subject expressed IL-4 ( Fig. 1C) . The low frequency of T FH cells that express IL-4 was confirmed in twelve different tonsil specimens ( Fig. 1D) .
Relatively low frequencies of IL-4 + CD4 + ICOS + and IL-4 + ICOS + Bcl6 + T FH cells were also observed in normal mesenteric lymph nodes in addition to tonsillar samples (Figs 1E) .
In order to more directly examine germinal center T FH cells, we initially localized germinal centers in twelve different human tonsils using staining for Bcl-6 and then analyzed CD4 + Bcl-6 + IL-4 + T cells ( Fig. 2A ). These analyses also revealed that CD4 + Bcl-6 + IL-4 + germinal center T FH cells represented a very small proportion (ranging from 1-10%) of all germinal center T FH cells.
CD4 + CXCR5 + IL-4 + T FH cells are abundant in IgG4-RD but rare in normal secondary lymphoid organs and in Sjögren's syndrome.
We analyzed secondary lymphoid organs from healthy individuals and affected tertiary lymphoid organs (TLO) in submandibular glands from IgG4-RD subjects with active disease for IL-4 synthesizing T FH cells and focused our analyses in the vicinity of TLO-like structures containing germinal centers. TLOs with germinal centers (Ruddle, 2014) were identified using multi-color immunofluorescence approaches (CD4, CD19, Bcl6, and DAPI). In this study, 17 of 25 (68%) patients with IgG4-RD and 7 of 15 (47%) patients with severe Sjögren's syndrome (SS) had TLOs in affected salivary glands (Table S3 ).
Germinal centers within TLOs were both more frequent and larger in salivary glands from IgG4-RD than severe SS (Table S3 ). As seen in Fig. 2B , CD4 + CXCR5 + IL-4 + cells were found in human tonsils and lymph nodes, but were sparse. In contrast, these CD4 + CXCR5 + IL-4 + T FH cells were abundant in IgG4-RD. Quantitation of CD4 + CXCR5 + IL-4 + T FH cells revealed that about 67% of CD4 + CXCR5 + T FH cells in an IgG4-RD subject expressed IL-4, while fewer than 5% of tonsillar CD4 + CXCR5 + T FH cells expressed IL-4 ( Fig. 2B ). CD4 + CXCR5 + IL-4 + T FH and CD4 + ICOS + IL-4 + T FH cells are clearly far more abundant in IgG4-RD than in normal secondary lymphoid organs in or around TLOs from affected tissues from subjects with SS ( Fig. 2B) .
We extended our studies to lymph nodes from subjects with IgG4-RD.
Quantification revealed that almost all IL-4 expressing CD4 + T cells in IgG4-RD lymph nodes were CXCR5 + T FH cells (Fig. 2C ).
IL-4 + BATF + T FH cells are rare in normal secondary lymphoid organs but abundant in IgG4-RD
The regulation of IL-4 expression in murine T FH cells is distinct from the mechanisms that drive IL-4 expression in T H2 cells. BATF is a transcription factor that may regulate IL-4 secretion by murine T FH cells (Sahoo et al., 2015) , but may more broadly help identify T FH cells, some of which do not necessarily express IL-4 (Weinstein et al., 2016) . Many CD4 + IL-4 + T cells in the vicinity of germinal centers in affected IgG4-RD tissues express nuclear BATF ( Fig. 2D ).
Not surprisingly, quantification revealed that these IL-4 expressing CD4 + BATF + T cells are abundant in IgG4-RD tissue lesions but rare in normal SLOs ( Fig.   2E ). Using parallel sections of tissues from an IgG4-RD subject, we noted that CD4 + BATF + IL-4 + T cells were located in the same region in which IL-4 expressing CD4 + CXCR5 + T FH cells were observed. Quantification of CXCR5 + BATF + IL-4 + cells revealed that about 60% of CXCR5 + IL-4 + cells in an IgG4-RD subject with TLOs expressed BATF ( Fig. 2F ).
We considered the possibility that the expansion of these IL-4 expressing T FH cells might represent an important disease-related T FH subset and contribute to the specific class switch event in IgG4-RD. ICOS + BATF + T FH cells are far more abundant in IgG4-RD lymph nodes than in normal tonsils ( Fig. 2G ). As seen in Figure 2H , ICOS + BATF + IL-4 + T FH cells were detected in IgG4-RD patients, and these cells were abundant. Quantification of ICOS + BATF + IL-4 + T FH cells revealed that about 60% of ICOS + IL-4 + T FH cells in an IgG4-RD lymph node subject expressed BATF ( Fig. 2I ). Furthermore, quantification revealed that the majority of ICOS + BATF + T FH cells in IgG4-RD lymph nodes expressed IL-4 as well ( Fig. 2I ). Interestingly, quantification of CD40L + BATF + IL-4 + T cells revealed that these cells represented approximately 98% of CD40L + BATF + T cells in an IgG4-RD subject (Fig. 2J ). These data indicate that a large number of lesional IL-4 + T FH cells in IgG4-RD express BATF, CD40L and ICOS.
IL-4 secreting T FH cells are a distinct population of T follicular helper cells
Although visualization by multicolor staining permits anatomic localization of T FH cells in tissues, it can provide only limited information about a few expressed proteins in any putative T FH cell subset, and a detailed characterization of any specific cytokine secreting T FH subset is currently lacking. In order to better understand the biology of IL-4 secreting T FH cells found in lymphoid organs, we performed RNA-seq analysis of viable IL-4 secreting T FH cells from human tonsils.
Although the fraction of IL-4 producing T FH cells is low in human tonsils, we were able to purify this subset by starting with 600 million tonsil cells, using an IL-4 cytokine capture strategy. To promote cytokine secretion, CD19-depleted lymphocytes from tonsils were stimulated overnight with plate-coated anti-CD3 and anti-CD28 antibodies. We then compared the transcriptome of FACS sorted IL-4 producing T FH cells to CXCR5 hi PD1 hi T FH cells that did not secrete IL-4, as well as IL-4-secreting CD45RA -CXCR5non-T FH cells obtained from the same tonsil ( Figure 3A ). CD4 + CD45RA + naïve cells were also included as an additional control. Of the 26,002 mapped transcripts, 7,792 were differentially expressed across the four conditions ( Figure 3B ). The IL-4 producing and non-producing T FH cells were most similar, and markedly dissimilar from IL4-secreting non-T FH cells or naïve CD4 + T cells ( Figure 3C ). In contrast to the IL-4 producing non-T FH cells that express high levels of IL-4, IL-5 and IL-13, reflecting a T H2 signature, IL-4 producing T FH cells express only IL-4 but much lower levels of IL-5 and IL-13 ( Figure 3D ). In order to examine lineage-defining genetic regulators and functionally relevant effector molecules, we focused our analysis on differentially expressed CD molecules, transcription factors and cytokines ( Figure 3E ). The transcript level of genes critical to T FH function such as CD40L, ICOS, CXCR5, IL-21R and PD1 was highest in the IL4-secreting T FH cells. In addition, they also expressed high levels of CCR4, CD200, CTLA4, GITR and low levels of CD6, CD27, CD28, SELL, IL-7R and CD74. Although the expression levels of these cell surface markers are derived from in vitro activation during cytokine capture, the CD markers specific for cells with an IL-4 secreting T FH phenotype may aid in the specific flow cytometric identification of ex vivo human IL-4 secreting T FH cells in future studies. As expected, CD4 + CD45RA + cells had the highest level of CCR7, CD27 and CD62L. The high expression levels of multiple chemokines, cytokines and their receptors including CCR2, CCR6, CXCR3, CXCR6, IL-2RA, IL-2RB, IL-10RA, CCL4, IFNG, IL-2, IL-3, IL-4, IL-5, IL-9, IL-10, IL-17A, IL-22 and IL-23A within the IL4-producing CD4 + CD45RAnon-T FH cells perhaps indicate the heterogeneity among these cells, and may reflect the overlap and plasticity between T H1 , T H2 and T H17 subsets that is seen following TCR stimulation in the absence of polarizing cytokines (i.e., anti-CD3 and anti-CD28 alone). Interestingly, the IL-4 producing T FH cells express the highest levels of BCL6 and BATF in this comparison, but not transcription factors related to T H2 differentiation such as GATA3, STAT5A and PRDM1 (BLIMP1), which are instead abundantly expressed in the IL-4-producing non-T FH population, which is likely enriched for T H2 cells.
Furthermore, the expression of all the markers that we studied using immunofluorescence in IL-4 expressing T FH cells from IgG4-RD tissues (BCL6, ICOS, IL-4, CXCR5, BATF, GATA3 and PD1) were consistent with the RNA-seq observations on the tonsillar IL-4 secreting T FH cells.
CD4 + CXCR5 + IL-4 + T FH cells are mainly outside germinal centers in IgG4-RD and sometimes physically associate with AID expressing B cells
As seen in Figure 4A , CD4 + CXCR5 + IL-4 + T FH cells were abundant in affected IgG4-RD tissues and were mainly outside germinal centers, but were also located in the light zone within GCs. Using parallel tissue-sections, we noted (Fig. 4B ). We also noted the existence of IL-has been reported earlier, much of the AID staining seen is cytosolic (Cattoretti et al., 2006) . Furthermore, we noted the existence of IL-4 + ICOS + and BATF + ICOS + T FH cells that are in cell-cell contact with IgG4 expressing B cells ( Fig. 4E and 4F) , confirming visual contact with nuclear distance measurements. AID + IgG4 + B cells were also visualized within and outside GCs in TLOs in IgG4-RD.
CD4 + CXCR5 + IL-4 + T FH cells and CD4 + IL-4 + BATF + T cells are enriched in
IgG4-RD, and their proportions are tightly linked to serum IgG4 levels and the proportion of IgG4 positive plasma cells in tissues
As seen in Fig. 5A , only a small proportion of CD4 + CXCR5 + T FH cells in tonsils, mesenteric and cervical lymph nodes from normal individuals and also in or around TLOs from affected tissues from subjects with SS synthesize IL-4.
These data argue that IL-4 expression is not generally a part of the T FH phenotype in cells located in secondary or tertiary lymphoid organs. Instead, what is more likely is that a subset of activated T FH cells that expresses IL-4 expands considerably in a disease in which there is a prominent IgG4 class switch, but these cells are not abundant around GCs in healthy people or in TLOs from other diseases in which there is no prominent switch to the IgG4 or IgE isotypes. The proportion of T FH cells that express IL-4 in disease tissue correlates very strongly with the serum IgG4 levels in IgG4-RD subjects, but not with total serum IgG, IgE or IgA levels ( Fig. 5B) . A negative correlation with serum IgM levels was also observed (Fig. 5B ). The proportion of CD4 + CXCR5 + cells that express IL-4 in IgG4-RD also correlates with the proportion of IgG4 expressing plasma cells in disease tissues (Fig. 5C ). The proportions of CD4 + BATF + IL-4 + T cells correlate with CD4 + CXCR5 + IL-4 + T FH cells and with serum IgG4 levels ( Fig. 5D ).
DISCUSSION
In T-dependent immune responses, it is widely accepted that specific cytokines induce the transcription of selected switch regions so that distinct Ig gene loci are targeted by AID for the induction of cytidine deamination and double strand break formation. However, a link between subsets of T FH cells and specific isotype switching events has not been established.
We found that very few T FH cells in healthy tonsils or lymph nodes synthesize IL-4. These findings are broadly consistent with published data on human tonsillar T FH cells using different approaches (Bentebibel et al., 2011; Kroenke et al., 2012; Ma et al., 2009) IL-4 secreting T FH cells have never been purified from lymphoid organs and cannot be distinguished in human lymphoid organs by the expression of specific chemokine receptors. To reliably characterize a specific cytokinesecreting T FH population, we used a specific IL-4 capture assay and compared the transcriptomes of IL-4 producing human tonsillar T FH cells to non-T FH cells from the tonsil that secrete IL-4, and human tonsillar PD-1 hi T FH cells that do not secrete IL-4. IL-4 secreting T FH cells stand out as a distinct subset. It is reasonable to consider that these IL-4 secreting BATF expressing T FH cells, which do not express GATA-3, represent an activated T FH population or subset in secondary and tertiary lymphoid organs that are expanded in disease that may contribute to class switching to IgG4. Unlike T H2 cells, which produce IL-4, IL-5 and IL-13, the IL4-producing tonsillar T FH cells produce IL-4 and IL-10, but not IL-5 or IL-13. This subset of T FH cells has a unique transcriptional profile and a distinct set of surface markers that will facilitate future functional studies.
The mechanisms and signals by which antibodies class switch to IgG4 is poorly understood. CD4 + T cells can activate IgM-positive B cells to switch to IgG4 and IgE in the presence of added IL-4 (Gascan et al., 1991) . It has been argued based on in vitro studies that IL-10 may contribute to the IgG4 class switch indirectly by somehow facilitating IL-4 mediated switching to IgG4 in preference to IgE (Jeannin et al., 1998) . No molecular or cellular explanation has emerged for this in vitro phenomenon. Arguments have also been made that switching to IgG4 is a result of repeated division, and that switching progresses sequentially along chromosome 14 from IgG1 to IgG3 to IgG2 to IgG4 (Tangye et al., 2002) (Jackson et al., 2014) . We do not presume that IL-4 secreting T FH cells alone contribute to the IgG4 class switch, though it is possible that the same subset of IL-4 secreting T FH cells that we have characterized might, in certain contexts, make enough IL-10 to facilitate this switching event. Perhaps more efficient purification of this T FH subset using surface markers inferred from our transcriptomic data will facilitate future functional studies on IL-4 secreting T FH cells. Tissue sources of IL-10 or of other factors that work in concert with IL-4 from these specific T FH cells will also need to be explored in future studies.
These studies are the first demonstration of an in situ expansion of what may be construed to be a human T FH subset. Many diseases exist in which IgE dominates in the absence of IgG4 and vice versa. Our data indicate that only a fraction of T FH cells in secondary and tertiary lymphoid organs, mainly outside germinal centers, express BATF and IL-4. However, we have shown here that these IL-4 expressing T FH cells accumulate in tertiary lymphoid organs of subjects with IgG4-RD. There is therefore a disease-specific increase in the accumulation of a subset of T FH cells and a tight association between the numbers of these cells and class switching, specifically to IgG4. Whether there are further subsets of BATF and IL-4 expressing T FH cells that separately facilitate the IgG4 or IgE class switch remains to be ascertained using single cell approaches.
METHODS
Study population
Submandibular glands (SMGs) were obtained from 17 Japanese patients with IgG4-RD, from affected lymph nodes of 6 patients with IgG4-RD, and from lacrimal and salivary glands (LSGs) of 7 patients with active Sjögren's Syndrome (SS). In addition, 2 unaffected cervical lymph nodes, 3 mesenteric lymph nodes and 12 healthy human tonsils were obtained that were histologically normal. All of these IgG4-RD patients had been followed up between 2007 and 2015 at the Department of Oral and Maxillofacial Surgery of Kyushu University Hospital, a tertiary care center. Open SMG biopsies were obtained from patients with IgG4-RD (Moriyama et al., 2014) . IgG4-RD was diagnosed according to the following criteria (Umehara et al., 2012) : 1) persistent (longer than 3 months) symmetrical swelling of more than two lacrimal and major salivary glands; 2) high (>135 mg/dl) serum concentrations of IgG4; and 3) infiltration of IgG4-positive plasma cells into tissue (IgG4 + cells/IgG + cells >40%), as determined by immunostaining.
All SMGs from patients with IgG4-RD had histopathologic features of IgG4-RD.
The age, sex, serum immunoglobulin and specific autoantibody levels of 17 IgG4-RD patients (G1-G17) whose affected salivary gland biopsies were analyzed by ex vivo in situ immunofluorescence studies are summarized in Table S1A . The age, sex, serum immunoglobulin and specific autoantibody levels of 6 IgG4-RD patients (LN1-LN6) whose affected lymph node biopsies were analyzed by ex vivo in situ immunofluorescence studies are summarized in Table S2 .
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Each SS patient exhibited objective evidence of salivary gland involvement based on the presence of subjective xerostomia and a decreased salivary flow rate, abnormal findings on parotid sialography and focal lymphocytic infiltrates in the LSGs by histology (Vitali et al., 2002) . All SS patients were severe cases and had developed abundant TLOs in each salivary gland. None of the IgG4-RD and SS patients had a history of treatment with steroids or other immunosuppressants, infection with HIV, hepatitis B virus, or hepatitis C virus, or sarcoidosis, and none had evidence of malignant lymphoma at the time of the study. The age, sex, serum immunoglobulin and specific autoantibody levels of SS patients whose salivary gland biopsies were analyzed by in situ immunofluorescence are summarized in Table S1B . The study protocol was approved by the Ethics Committee of Kyushu University, Japan and the Institutional Review Board at Massachusetts General Hospital. All included disease subjects provided written informed consent.
Multi-color immunofluorescence staining
Tissue samples were fixed in formalin, embedded in paraffin, and sectioned. 
Microscopy and quantitative image analysis
Images of the salivary gland specimens were acquired using the TissueFAXS platform (TissueGnostics). For quantitative analysis, the entire area of the tissue involved by the lymphoplasmacytic infiltrate was acquired as digital greyscale images in four channels with filter settings for FITC, Cy3 and Cy5 in addition to DAPI. Cells of a given phenotype were identified and quantitated using the TissueQuest software (TissueGnostics), with cut off values determined relative to the positive controls. This microscopy-based multicolor tissue cytometry software permits multicolor analysis of single cells within tissue sections similar to flow cytometry. The principle of the method and the algorithms used have been described in detail elsewhere (Ecker and Steiner, 2004) .
Evaluation of TLOs with IgG4-RD and SS
TLOs with germinal centers (Ruddle, 2014) were identified by using multicolor immunofluorescence approaches (CD4, CD19, Bcl6, and DAPI). In this study, SMG and LSG tissue sections from 25 patients with IgG4-RD and 15 patients with severe SS were evaluated. Distinct Bcl-6 + germinal centers were observed in affected IgG4-RD tissues. Bcl-6 + germinal center B cells in TLOs were within B cell follicles, delineated using antibodies to CD19. Seventeen of 25 (68%) patients with IgG4-RD had TLOs in affected salivary glands. The age, sex, serum immunoglobulin and specific autoantibody levels of 17 IgG4-RD patients (G1-G17) whose affected salivary gland biopsies were analyzed by in situ immunofluorescence are summarized in Table S1A . Seven of 15 (47%) patients with severe SS had TLOs in affected salivary glands. The age, sex, serum immunoglobulin and specific autoantibody levels of SS patients whose salivary gland biopsies were analyzed in this study are summarized in Table SS1B .
The number of TLOs with germinal centers and the size of germinal centers in each TLOs was evaluated in 4mm 2 sections from five different areas of 17 IgG4-RD patients (G1-G17) and 7 SS patients (SS1-SS7) (Table S3 ).
IL-4 capture assay and cell sorting
600 million cells from human tonsil were re-suspended in Miltenyi MACS buffer and stained with biotinylated anti-human CD19 (clone HIB19, Biolegend) on ice for 25 minutes. Cells were washed once in MACS buffer and incubated with anti-biotin microbeads (Miltenyi Biotec) for 25 minutes on ice. Cells were then loaded on two separate Miltenyi LS columns (at 300 million cells per column) and the flow-through was collected as the B cell depleted fraction. These cells were spun down and stimulated overnight with plate coated anti-CD3 (5µg/ml) and anti-CD28 (5µg/ml).
The stimulated cells were then enriched for IL-4-secreting cells using the vendor's protocol (Miltenyi Biotec IL-4 Secretion Assay kit, #130-054-101). The enriched IL-4+ cell fraction was surface stained with antibodies against CD4 (BioLegend #317420), CD45RA (clone H100, BioLegend #304122), CXCR5 (clone J252D4, BioLegend #356920), and PD1 (clone EH12.2H7, BioLegend #329924). The following populations were viably sorted using FACSAria2 (Becton Dickinson) directly into Qiagen RLT-plus buffer (with 1% 2-mercaptoethanol): (i) IL4-secreting CD4+CXCR5+ TFH cells, (ii) IL4-secreting CD4+CD45RA-CXCR5-Th2 cells, (iii) IL4-negative CD4+CXCR5+PD1+ TFH cells, and (iv) IL4-negative CD45RA+ cells.
Trancriptomic analyses
Total RNA was isolated from the FACS-sorted cells using the RNeasy plus Micro Kit (Qiagen, USA). RNA sequencing (RNA-Seq) libraries were prepared as previously described (Picelli. et al., 2013) . Briefly, whole transcriptome amplification (WTA) and tagmentation-based library preparation were performed using the SMART-Seq2 protocol, followed by 35-base pair paired-end sequencing on a NextSeq 500 instrument (Illumina). 5-10 million reads were obtained from each sample and aligned to the UCSC hg38 transcriptome. Gene expression was calculated using RSEM as previously described (Li and Dewey, 2011) . The EBSeq package was used to identify differentially expressed genes with a posterior probability of differential expression (PPDE) > 0.95 (Leng et al., 2013) . Our analysis focused on cytokines, transcription factors and CD molecules. Cytokines and transcription factors were obtained using the gene ontology terms GO:0003700 and GO:0005125, respectively. Transcription factors pertaining to immune cells were filtered using a literature-based gene prioritization approach with the query terms "immune response", "immunity", "T cells" and "lymphocytes" (Fontaine et al., 2011) . The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE111968 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111968)
Statistical analyses
Differences between groups were determined by the X 2 test, Student t test, Mann-Whitney U test and Spearman rank correlations. All statistical analyses were performed using JMP Pro software, version 11 (SAS Institute, Cary, NC, USA) for Mac. P values less than 0.05 were considered statistically significant. Nonsignificant differences were not specified. In all figures, bar charts and error bars represent the means ± SEM, respectively. ND, not done. Table S3 . Difference in TLOs between patients with IgG4-RD and SS. †Significance of the difference between the two groups was determined by X 2 tests. † †Significance of the difference between the two groups was determined by the Student t test. Naive  TFH  IL4-neg   non-TFH  IL4-pos   TFH  IL4-pos   CD40LG, LTA, LTB, IL32, NAMPT, IL21, IL17F   FASLG, TNFSF8, CD70, CSF1, CSF2, IFNG, IL2, IL3, IL4, IL5, IL9, IL10, IL13, IL17A, CCL4,  TIMP1, TNF, TNFSF11, TNFSF14, TNFSF10, AIMP1, FAM3C, IL22, IL23A   FLT3LG, IL16, MIF, TNFSF13B HMGB1, EBI3, CMTM6, CMTM7, TXLNA STAT1, HMGB1, RELA, NFE2L2, STAT2, RELB, TRIM22, IRF9, SP1, YY1, ETS1, RB1, ATF4 CREB1, STAT5B, HIF1A, BCL6, MYC, NR3C1, XBP1, KLF6, BATF NFATC2, JUN, STAT5A, NOTCH1, PRDM1, GATA3, EGR1, NFATC1, TRIM25, CREBBP, NFAT5, VDR, NCOR1 NFKB1, STAT6, IRF4, REL, KLF10, PA2G4, CREM, FOSL1, HIVEP3, TCF3, HNRNPAB ADAM8, CCR2, CCR6, CD109, CD2, CD226, CD274, CD46, CD63, CD70, CD83, CD84, CD86, CXCR3, CXCR6, FASLG, GGT1, IGF2R, IL10RA, IL2RA, IL2RB, ITGB1, LAG3, LAIR2, MS4A1, PLAUR, PRNP, PTPRJ, S1PR1, SLAMF1, TNFRSF10A, TNFRSF12A, TNFRSF1B, TNFRSF4, TNFSF10, TNFSF11, TNFSF14, TNFSF8 ADAM17, ATP1B3, BTLA, CCR4, CD200, CD320, CD38, CD40LG, CD44, CD58, CD82, CTLA4, CXCR5, ICAM1, ICOS, IL1R2, IL21R, LY75, PDCD1, SLC7A5, TFRC, TNFRSF18, TNFRSF9 BTN3A1, CD247, CD47, CD52, CD69, CD74, CD96, CD99, IL7R, SELPLG, SEMA4D, TNFRSF14, TNFRSF1A BST2, CD164, CD37, CD3D, CD3E, CD3G, CD4, CD53, CD59, CD7, CD79B, CD8B, CXCR4, EVI2B, FAS, ICAM3, IFITM1, IFNGR1, IL10RB, IL6R, ITGAE, ITGAL, KLRB1, LAMP2, SIRPG, SLAMF6, TNFRSF8 CCR7, CD27, CD28, CD48, CD55, CD6, DPP4, GYPC, ICAM2, LY9, PTPRC, SELL, SLAMF7, TNFSF13B 2 IL4-positive non-TFH (CD4 + CD45RA -CXCR5 -IL4 + ) IL3  IL22  IL10  IL17A  IL21  IL9  IL1A  IL15  IL32  IL16  IL17F  IL4  IFNG  IL2  IL23A  IL5  IL13 
CD molecules
